Anti-platelet resistance in patients with myeloproliferative neoplasms

• Research type

  Research Study

• Full title

  Assessment of anti-platelet drug sensitivity in myeloproliferative disorders in those treated with hydroxycarbamide or anagrelide

• IRAS ID

  112611

• Contact name

  Bethan Myers

• Contact email

  bethan.myers@ulh.nhs.uk

• Sponsor organisation

  United Lincolnshire Hospitals

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  13/NW/0226

• Date of REC Opinion

  22 Mar 2013

• REC opinion

  Favourable Opinion